Cogstate Announces Formation of Scientific Advisory Board
June 14, 2022 10:52 ET
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, June 14, 2022 (GLOBE NEWSWIRE) -- Cogstate (ASX.CGS) a leading neuroscience technology company, today announced the formation of a Scientific Advisory...
EISAI TO LAUNCH DIGITAL TOOL "CogMate™ IN TAIWAN AND HONG KONG
January 12, 2022 21:19 ET
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Cogstate (ASX.CGS), via its global commercial partner Eisai Co., Ltd, is pleased to announce that Cogstate technology...
Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod
December 01, 2021 11:33 ET
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced its digital cognitive assessments were part of the...
Leaders from Cogstate Join the Davos Alzheimer’s Collaborative to Accelerate Innovation and Preparedness for Disease Interventions
November 16, 2020 07:48 ET
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today that four members of its executive...
Cogstate Expands Executive Team with Key Scientific Appointments
October 01, 2020 08:00 ET
|
Cogstate Ltd.
Melbourne, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today the appointment of Chris Edgar, PhD as Chief Science Officer and Prof. Paul...
Cogstate Receives Digital Biomarker Award from ADDF to Develop Mobile App for Early Detection of Memory Impairment
April 29, 2020 10:30 ET
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, April 29, 2020 (GLOBE NEWSWIRE) -- Cogstate Ltd (ASX:CGS) today announced an award from the Alzheimer's Drug Discovery Foundation’s (ADDF) Diagnostics...
Cogstate Expands Executive Team, Appointing Ken Billard as Chief Commercial Officer
November 19, 2019 08:00 ET
|
Cogstate Ltd.
New Haven, CT, Nov. 19, 2019 (GLOBE NEWSWIRE) -- The neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today that Ken Billard has joined the company in the role of Chief Commercial...
Cogstate Establishes Rare Disease and Pediatric Center of Excellence
April 05, 2018 09:16 ET
|
Cogstate Ltd.
New Haven, CT, April 05, 2018 (GLOBE NEWSWIRE) -- The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the establishment of a Rare Disease and Pediatric Center of Excellence to lead...